Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor
go back to main search page
Accession:CHEBI:76835 term browser browse the term
Definition:An EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor that uses NAD(+) or NADP(+) as acceptor (EC 1.1.1.*).
Synonyms:related_synonym: EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+)acceptor) inhibitors;   EC 1.1.1.* inhibitor;   EC 1.1.1.* inhibitors


show annotations for term's descendants           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19785
    role 19732
      biological role 19732
        biochemical role 19281
          enzyme inhibitor 18148
            EC 1.* (oxidoreductase) inhibitor 16512
              EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor 5777
                EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor 4082
                  EC 1.1.1.1 (alcohol dehydrogenase) inhibitor + 29
                  EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor + 209
                  EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor + 1209
                  EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor + 33
                  EC 1.1.1.159 (7alpha-hydroxysteroid dehydrogenase) inhibitor + 0
                  EC 1.1.1.170 [3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating)] inhibitor + 0
                  EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor + 258
                  EC 1.1.1.188 (prostaglandin-F synthase) inhibitor + 646
                  EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor + 517
                  EC 1.1.1.205 (IMP dehydrogenase) inhibitor + 919
                  EC 1.1.1.21 (aldehyde reductase) inhibitor + 1169
                  EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitor + 9
                  EC 1.1.1.25 (shikimate dehydrogenase) inhibitor + 2016
                  EC 1.1.1.267 (1-deoxy-D-xylulose-5-phosphate reductoisomerase) inhibitor + 0
                  EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor + 974
                  EC 1.1.1.37 (malate dehydrogenase) inhibitor + 0
                  EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor + 0
                  EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor + 13
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.